inflammation and glp-1 Drugs: For Multiple Chronic Conditions Emerging Frontiers in GLP-1 Therapeutics:
Description
Prescription of glucagon-like peptide 1 agonists and risk of subsequent open-angle glaucoma in individuals with type 2 diabetes mellitus
2024 doi: 10.1038/s41591-024-02996-7
The absolute number of DVT events across all 21 trials was small, which is exactly why the confidence interval stretches so wide, from 1.09 to 12.25
Semaglutide is a GLP-1 receptor agonist that mimics this hormone, reducing hunger, slowing digestion, and improving insulin signaling
Detoxes, extra water, or special foods do not speed up clearance
The drugs benefits are clear, but their vast benefits could also be a double-edged sword
